Cancer & Therapeutics

Cancer Therapeutics aims to address the challenges of tumour heterogeneity, cancer development, and drug resistance by utilising a growing number of technologies available to doctors in the treatment of this illness. It has gone through a paradigm shift away from classic cytotoxic medications and toward targeting proteins that are fundamental to the cancer phenotype. The discovery and development of HSP90 inhibitors has been sought by cancer therapies as a means of avoiding or overcoming medication resistance. All anticancer drugs work by inhibiting cell growth or normal function, DNA synthesis, and RNA and protein metabolite blocking or alteration.

  • Cancer stem cells
  • Kinase inhibitors
  • Personalised medicine
  • Protein–protein interactions

    Related Conference of Cancer & Therapeutics

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Cancer & Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in